Muhlenkamp & Company 13F, Q2 2023
Muhlenkamp · quarter ending 30 June 2023 · filed 14 July 2023 · SEC CIK 1133219
$282.19M
Filed US book
31
Positions
6.5%
Largest position
Common stock only: shares the fund reported owning at the quarter end, valued as filed.
Largest positions, Q2 2023
The 25 largest of 31 positions. Weights are against the whole filed book.
| Company | Ticker | Value | % of book |
|---|---|---|---|
| EQT CORP | EQT | $18.33M | 6.5% |
| MCKESSON CORP | MCK | $16.38M | 5.8% |
| SCHLUMBERGER LTD | SLB | $15.31M | 5.4% |
| MASTEC INC | MTZ | $15.08M | 5.3% |
| RUSH ENTERPRISES INC | RUSHA | $14.56M | 5.2% |
| BROADCOM INC | AVGO | $13.91M | 4.9% |
| OCCIDENTAL PETE CORP | OXY | $13.69M | 4.8% |
| KIRBY CORP | KEX | $12.87M | 4.6% |
| BERKSHIRE HATHAWAY INC DEL | BRK/B | $12.84M | 4.5% |
| UNITEDHEALTH GROUP INC | UNH | $11.89M | 4.2% |
| NMI HLDGS INC | NMIH | $11.77M | 4.2% |
| APPLE INC | AAPL | $11.71M | 4.2% |
| DOW INC | DOW | $11.60M | 4.1% |
| MICROSOFT CORP | MSFT | $10.52M | 3.7% |
| SPDR SER TR | KRE | $10.18M | 3.6% |
| MICROCHIP TECHNOLOGY INC. | MCHP | $10.01M | 3.5% |
| BRISTOL-MYERS SQUIBB CO | BMY | $8.29M | 2.9% |
| CVS HEALTH CORP | CVS | $7.65M | 2.7% |
| BGC PARTNERS INC | $6.94M | 2.5% | |
| ALPS ETF TR | AMLP | $6.84M | 2.4% |
| FRANCO NEV CORP | FNV | $6.81M | 2.4% |
| ROYAL GOLD INC | RGLD | $6.53M | 2.3% |
| WABTEC | WAB | $6.07M | 2.1% |
| TRANSOCEAN LTD | $6.00M | 2.1% | |
| PULTE GROUP INC | PHM | $4.24M | 1.5% |
This is the earliest Muhlenkamp & Company 13F we hold, so there is no earlier filing here to compare it with.
Other quarters
Source: SEC Form 13F-HR, accession 0001133219-23-000004, filed by MUHLENKAMP & CO INC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.